thelancet.com
Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial
Spironolactone was the most effective add-on drug for the treatment of resistant hypertension.
The superiority of spironolactone supports a primary role of sodium retention in this
condition.